GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (NAS:PAHC) » Definitions » Cyclically Adjusted Price-to-FCF

Phibro Animal Health (Phibro Animal Health) Cyclically Adjusted Price-to-FCF : 27.38 (As of Apr. 30, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Cyclically Adjusted Price-to-FCF?

As of today (2024-04-30), Phibro Animal Health's current share price is $16.70. Phibro Animal Health's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $0.61. Phibro Animal Health's Cyclically Adjusted Price-to-FCF for today is 27.38.

The historical rank and industry rank for Phibro Animal Health's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

PAHC' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 15.84   Med: 24.48   Max: 29.76
Current: 27.64

During the past years, Phibro Animal Health's highest Cyclically Adjusted Price-to-FCF was 29.76. The lowest was 15.84. And the median was 24.48.

PAHC's Cyclically Adjusted Price-to-FCF is ranked better than
66.36% of 327 companies
in the Drug Manufacturers industry
Industry Median: 32.38 vs PAHC: 27.64

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Phibro Animal Health's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.509. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.61 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Phibro Animal Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Phibro Animal Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Cyclically Adjusted Price-to-FCF Chart

Phibro Animal Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 26.90 24.43

Phibro Animal Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.17 28.08 24.43 21.06 19.07

Competitive Comparison of Phibro Animal Health's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Cyclically Adjusted Price-to-FCF falls into.



Phibro Animal Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Phibro Animal Health's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=16.70/0.61
=27.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phibro Animal Health's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Phibro Animal Health's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.509/129.4194*129.4194
=0.509

Current CPI (Dec. 2023) = 129.4194.

Phibro Animal Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.139 99.695 -0.180
201406 -0.613 100.560 -0.789
201409 0.338 100.428 0.436
201412 0.117 99.070 0.153
201503 0.393 99.621 0.511
201506 0.373 100.684 0.479
201509 -0.262 100.392 -0.338
201512 -0.039 99.792 -0.051
201603 -0.149 100.470 -0.192
201606 0.474 101.688 0.603
201609 0.390 101.861 0.496
201612 0.541 101.863 0.687
201703 0.805 102.862 1.013
201706 0.201 103.349 0.252
201709 -0.005 104.136 -0.006
201712 0.705 104.011 0.877
201803 0.461 105.290 0.567
201806 0.113 106.317 0.138
201809 -0.118 106.507 -0.143
201812 0.229 105.998 0.280
201903 0.197 107.251 0.238
201906 0.117 108.070 0.140
201909 -0.278 108.329 -0.332
201912 0.584 108.420 0.697
202003 0.471 108.902 0.560
202006 -0.153 108.767 -0.182
202009 -0.141 109.815 -0.166
202012 0.484 109.897 0.570
202103 0.226 111.754 0.262
202106 -0.099 114.631 -0.112
202109 -0.090 115.734 -0.101
202112 0.307 117.630 0.338
202203 -0.096 121.301 -0.102
202206 -0.255 125.017 -0.264
202209 -0.836 125.227 -0.864
202212 -0.304 125.222 -0.314
202303 -0.041 127.348 -0.042
202306 0.231 128.729 0.232
202309 0.215 129.860 0.214
202312 0.509 129.419 0.509

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Phibro Animal Health  (NAS:PAHC) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Phibro Animal Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Phibro Animal Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Phibro Animal Health (Phibro Animal Health) Business Description

Traded in Other Exchanges
Address
300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Executives
Judith Weinstein officer: See Remarks C/O PHIBRO ANIMAL HEALTH CORP, 300 FRANK W. BURR BOULEVARD, STE 21, TEANECK NJ 07666
Alejandro Bernal director C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY NJ 07054
E Thomas Corcoran director
Larry Lee Miller officer: Chief Operating Officer 8 HAZELWOOD COURT, WARREN NJ 07059
Damian Finio officer: Chief Financial Officer C/O IGI LABORATORIES, INC., 105 LINCOLN AVENUE, BUENA NJ 08310
Robin Aukerman officer: President,North America Region C/O PHIBRO, GLENPOINTE CENTRE EAST, 3RD FL, 300 FRANK W. BURR BLVD, STE 21, TEANECK NJ 07666
Daniel M Bendheim director, officer: Exec. VP, Corporate Strategy 300 FRANK W. BURR BOULEVARD, SUITE 21, TEANECK NJ 07666
Dean J Warras officer: Pres Animal Health & Nutr N.A. 5113 SPYGLASS HILL, QUINCY IL 62305
Jack Bendheim director, 10 percent owner, officer: President and CEO C/O EMPIRE RESOURCES, INC., 1 PARKER PLAZA, SUIET 10, FORT LEE NJ 07024
Bfi Co., Llc 10 percent owner 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666
Jonathan Bendheim director GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ 07666
Anthony Andolino officer: SEE REMARKS GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., STE 21, TEANECK NJ 07666
Richard G Johnson officer: Chief Financial Officer 7 WEST 96TH STREET, APT. 11C, NEW YORK NY 10025
Gerald K Carlson director 2496 OLD BEACH ROAD, WAYZATA MN 55391
Thomas G Dagger officer: SVP, Gen Counsel and Corp Sec 41 WILCOX DRIVE, MOUNTAIN LAKES NJ 07046